article thumbnail

Project CBD Responds to the FDA’s 2023 Statement on CBD

Project CBD

A clinical trial by ValidCare assessing CBD’s impact on human liver function has given the compound a clean bill of health. The post Project CBD Responds to the FDA’s 2023 Statement on CBD appeared first on Project CBD. The FDA can’t scale with the scope and magnitude of popular interest in CBD.

CBD 130
article thumbnail

FDA Issues First Guidance on Clinical Trials for Psychedelic Drugs

Cannabis Law Report

Food and Drug Administration (FDA or Agency) on June 23, 2023, released its first draft guidance concerning design and desired features of clinical trials for psychedelic drugs LSD and MDMA There has been growing interest in studying the use of psychedelic drugs for […]

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Final Phase of MDMA Clinical Trials Shows Drug Is 90% Effective at Treating PTSD

SpeedWeed

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. If all goes well, the FDA could legalize MDMA-assisted therapy next year, which would make it legally available starting in 2023. Image via.

article thumbnail

European Regulatory Lead MAPS PBC Santa Cruz, CA

Cannabis Law Report

We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. Key Responsibilities.

article thumbnail

Defined Research To Present Results From Pioneering CBD Clinical Trial For Insomnia At Sleep 2023 Medical Conference

Medical Marijuana Program Connection

a science-based wellness company announces the results of its clinical trial for Defined Sleep, a. SAN FRANCISCO–(BUSINESS WIRE)–Defined Research, Inc., Read More

article thumbnail

The Cannabis Cancer Connection

Project CBD

Goldstrich, MD, with Angela Bacca (Flower Valley Press, 2023). They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM). GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising.

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Montana In Montana, two pieces of psychedelics reform legislation are being drafted for introduction in the 2023 session in Montana. Virginia There are multiple psychedelics proposals on the table for 2023. Missouri Rep.